NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
115 hedge funds and large institutions have $775M invested in NxStage Medical Inc. in 2014 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 41 reducing their positions, and 19 closing their positions.
934% more call options, than puts
Call options by funds: $4.98M | Put options by funds: $482K
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
11% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 19
10% more capital invested
Capital invested by funds: $701M → $775M (+$73.5M)
1% more funds holding
Funds holding: 114 → 115 (+1)
20% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$22.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$19M |
| 3 |
DM
Deerfield Management
New York
|
+$14.3M |
| 4 |
Millennium Management
New York
|
+$5.07M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$4.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$19.7M |
| 2 |
O
OrbiMed
New York
|
-$17.2M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$13.9M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$10.5M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$4.64M |
NXTM Hedge Fund Activity: Q2 2014 in Review
115 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q2 2014, worth a combined $775M — up 10% from $701M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new NXTM positions and 19 closed out — a net gain of 2 holders — while 33 added to existing stakes and 41 trimmed.
The largest buyer was RS Investment Management, opening a new position worth an estimated $22.4M. The largest seller was Massachusetts Financial Services, cutting an estimated $19.7M.
- 115 institutional investors held NxStage Medical Inc. (NXTM) as of Q2 2014, up from 114 in Q1 2014.
- Funds reported $775M of NxStage Medical Inc. stock for Q2 2014, up 10% quarter-over-quarter.
- 21 funds opened new NxStage Medical Inc. positions in Q2 2014 and 19 closed out, a net change of +2 holders.
- The largest NxStage Medical Inc. buyer in Q2 2014 was RS Investment Management, an estimated $22.4M added.
- The largest NxStage Medical Inc. seller in Q2 2014 was Massachusetts Financial Services, an estimated $19.7M sold.
Based on aggregated 13F filings for Q2 2014.